Form 4 for ARWR ARROWHEAD PHARMACEUTICALS, INC.
Accepted 2025-09-16 00:00:00 ET · period of report 2025-09-12 · accession 0001830755-25-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-16 | 2025-09-12 | ARWR | Hamilton James C | Chief Medical Off | S - Sale | $30.00 | -15.0K | 232.1K | -6% | -$450.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-12 | S | D | 15,000 | $30.00 | 232,122 | D | — | — | (F2) Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions. |